NeuroSense Therapeutics Ltd.
Organization details
- Legal name
- NeuroSense Therapeutics Ltd.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Israel
- Headquarters city
- Herzliya
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- NRSN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001875091
Board of directors
-
Cary J. Claiborne · DirectorSince 2026
-
Christine A. Pellizzari · DirectorSince 2026
-
Mark Leuchtenberger · DirectorSince 2026
-
Revital Mandil-Levin · DirectorSince 2026
-
Roy Golan · DirectorSince 2026
Board connections
3 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
Adial Pharmaceuticals Inc Same sectorvia Cary J. Claiborne
-
Imunon Inc. Same sectorvia Christine A. Pellizzari
- via Roy Golan
-
Tempest Therapeutics Inc. Same sectorvia Christine A. Pellizzari
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $400,000
- 2 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Ben-Noon Alon Officer (Chief Executive Officer) | Open-market purchase | +250,000 | $0.80 | $200,000 |
| Jun 16, 2026 | Eisenberg Or Officer (Chief Financial Officer) | Open-market purchase | +250,000 | $0.80 | $200,000 |
| Mar 26, 2026 | Russek-Blum Niva Officer (Chief Technology Officer) | Grant or award | +200,000 | — | — |
| Mar 26, 2026 | Binder Hagit Officer (General Manager) | Grant or award | +200,000 | — | — |
| Mar 26, 2026 | Eisenberg Or Officer (Chief Financial Officer) | Grant or award | +200,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about NeuroSense Therapeutics Ltd.
How many directors are on NeuroSense Therapeutics Ltd.'s board?
NeuroSense Therapeutics Ltd.'s board has 5 directors: Cary J. Claiborne, Christine A. Pellizzari, Mark Leuchtenberger, Revital Mandil-Levin and Roy Golan.
Are NeuroSense Therapeutics Ltd. insiders buying or selling shares?
Over the last 12 months, NeuroSense Therapeutics Ltd. insiders bought $400,000 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="neurosense-therapeutics-ltd"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.